Isoprostanes, prostanoids, and leukotrienes in exhaled breath condensate

New Perspectives in Monitoring Lung Inflammation: Analysis of Exhaled Breath Condensate

Volumn , Issue , 2004, Pages 53-66

  Montuschi, Paolo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056514254     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (60)

1. Busse, W.W., Leukotrienes and inflammation, Am. J. Respir. Crit. Care Med., 157, S210, 1998.
2. Drazen, J.M., Israel, E., and O’Byrne, P.M., Treatment of asthma with drugs modifying the leukotriene pathway, N. Engl. J. Med., 340, 197, 1999.
3. O’Byrne, P.M., Why does airway inflammation persist? Is it leukotrienes?, Am. J. Respir. Crit. Care Med., 161, S186, 2000.
4. Jatakanon, A. et al., Neutrophilic inflammation in severe persistent asthma, Am. J. Respir. Crit. Care Med., 160, 1532, 1999.
5. Hill, A.T., Bayley, D., and Stockley, R.A., The interrelationship of sputum inflammatory markers in patients with chronic bronchitis, Am. J. Respir. Crit. Care Med., 160, 893, 1999.
6. Zakrzewski, J.T. et al., Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease, Am. Rev. Respir. Dis., 136, 779, 1987.
7. 4 levels in patients with obstructive pulmonary disease, Chest, 99, 289, 1991.
8. 4 by alveolar macrophages, J. Clin. Invest., 88, 891, 1991.
9. Kilfeather, S., 5-Lipoxygenase inhibitors for the treatment of COPD, Chest, 121, 197S, 2002.
10. 2 in normal and asthmatic men, N. Engl. J. Med., 311, 209, 1984.
11. 2 on airway conductance in healthy subjects and asthmatic patients, Am. Rev. Respir. Dis., 111, 313, 1975.
12. 2 on allergen-induced airway responses and inflammation, Am. J. Respir. Crit. Care Med., 159, 31, 1999.
13. Noveral, J.P. and Grunstein, M.M., Role and mechanism of thromboxane-induced proliferation of cultured airway smooth muscle cells, Am. J. Physiol., 263, L555, 1992.
14. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism, Proc. Natl. Acad. Sci. USA, 87, 9383, 1990.
15. 2-isoprostanes as an index of oxidative stress in vivo, Free Radic. Biol. Med., 28, 505, 2000.
16. 2α, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro, Am. J. Respir. Crit. Care Med., 153, 590, 1996.
17. 2α induces airflow obstruction and airway plasma exudation in vivo. Am. J. Respir. Crit. Care Med., 155, 436, 1997.
18. Wenzel, S.E. et al., Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma, Am. J. Respir. Crit. Care Med., 152, 897, 1995.
19. 4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma, J. Allergy Clin. Immunol. 96, 643, 1995.
20. Kumlin, M., Measurement of leukotrienes in humans, Am. J. Respir. Crit. Care Med., 161, S102, 2000.
21. Nightingale, J.A., Rogers, D.F, and Barnes P.J., The effect of repeated sputum induction on cell counts in normal volunteers, Thorax, 53, 87, 1998.
22. Montuschi, P., Indirect monitoring of lung inflammation, Nat. Rev. Drug Discov., 1, 238, 2002.
23. Montuschi, P. and Barnes, P.J., Analysis of exhaled breath condensate for monitoring airway inflammation, Trends Pharmacol. Sci., 23, 232, 2002.
24. Carpenter, C.T., Price, P.V, and Christman, B.W, Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS, Chest, 114, 1653, 1998.
25. 2 measurements in exhaled breath condensate, Inflamm. Res., 52, 502, 2003.
26. Montuschi, P. et al., Measurements of exhaled prostanoids: reproducibility and flowdependence, Am. J. Respir. Crit. Care Med., 167, A752, 2003.
27. Montuschi, P., et al., Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients, Am. J. Respir. Crit. Care Med., 160, 216, 1999.
28. Montuschi, P. et al., Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers, Am. J. Respir. Crit. Care Med., 162, 1175, 2000.
29. Montuschi, P. et al., Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis, Thorax, 55, 205, 2000.
30. Montuschi, P. et al., Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide, Free Rad. Biol. Med., 33, 1403, 2002.
31. Antczak, A. et al., Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma, Am. J. Respir. Crit. Care Med., 166, 301, 2002.
32. 4 and 8- isoprostane in exhaled breath condensate of patients with exacerbations of COPD, Thorax, 58, 294, 2003.
33. Baraldi, E. et al., Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations, Thorax, 58, 505, 2003.
34. Kostikas, K. et al., pH in expired breath condensate of patients with inflammatory airway diseases, Am. J. Respir. Crit. Care Med., 165, 1364, 2002.
35. Kostikas, K. et al., Oxidative stress in expired breath condensate of patients with COPD, Chest, 124, 1373, 2003.
36. Carpagnano, G.E. et al., Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients, Chest, 122, 1162, 2002.
37. Carpagnano, G.E. et al., 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy, Chest, 124, 1386, 2003.
38. Montuschi, P. and Barnes, P.J., Exhaled leukotrienes and prostaglandins in asthma, J. Allergy Clin. Immunol., 109, 615, 2002.
39. 4 measurements in exhaled breath condensate, Inflamm. Res., 52, 69, 2003.
40. Montuschi, P. et al., Exhaled leukotrienes and prostaglandins in COPD. Thorax, 58, 585, 2003.
41. Hanazawa, T., Kharitonov, S.A., and Barnes, P.J., Increased nitrotyrosine in exhaled breath condensate of patients with asthma, Am. J. Respir. Crit. Care Med., 162, 1273, 2000.
42. Csoma, Z. et al., Increased leukotrienes in exhaled breath condensate in childhood asthma, Am. J. Respir. Crit. Care Med., 166, 1345, 2002.
43. Mondino, C. et al., Leukotrienes in exhaled breath condensate in childhood asthma, Am. J. Respir. Crit. Care Med., 167, A445, 2003.
44. 4 in patients with asthma, Am. J. Respir. Crit. Care Med., 163, A594, 2001.
45. Carpagnano, G.E. et al., Increased inflammatory markers in the exhaled breath condensate of cigarette smokers, Chest 124, 1386, 2003.
46. 4 and interleukin-6 in exhaled breath condensate in cystic fibrosis, Am. J. Respir. Crit. Care Med., 167, 1109, 2003.
47. 2 in expired breath condensate of patients with asthma, Eur. Respir. J., 22, 743, 2003.
48. van der Meer, R., et al., Levels of 8-isoprostane in exhaled breath condensate are not reproducible in asthmatic and normal subjects, Am. J. Respir. Crit. Care Med., 165, A14, 2002.
49. Anderson, D.G. et al., Biomarker reproducibility study in exhaled breath and induced sputum in non-smokers, smokers and COPD patients, Eur. Respir. J., 22, Suppl. 45, 77s, 2003.
50. Baraldi, E., et al., Increased exhaled 8-isoprostane in childhood asthma, Chest, 124, 25, 2003.
51. Montuschi, P., et al., Profile of prostanoids in exhaled breath condensate in childhood asthma, Eur. Respir. J., Suppl. 45, 400s, 2003.
52. 2α excretion in man, J. Pharmacol. Exp. Ther., 275, 94, 1995.
53. Vass, G. et al., Comparison of nasal and oral inhalation during exhaled breath condensate collection, Am. J. Respir. Crit. Care Med., 167, 850, 2003.
54. 2: a simple method of assessing pharmacologic effects on platelet function. Adv. Prostaglandin Thromboxane Res., 6, 187, 1980.
55. Huszar, E. et al., Thromboxane in exhaled breath condensate in healthy volunteers and in patients with asthma, Eur. Respir. J., Suppl. 45, 293s, 2003.
56. 2α in vitro and in vivo via the cyclooxygenases, J. Pharmacol. Exp. Ther., 282, 1658, 1997.
57. 2 in patients with chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med 163, A908, 2001.
58. 2α-III, an index of oxidant stress, Am. J. Respir. Crit. Care Med., 158, 1709, 1998.
59. 2, Lancet, 334, 436, 1995.
60. Sandrini, A. et al., Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma, Chest, 124, 1334, 2003.